![](/images/general/no_picture/200_user.png)
Daniel S Metzmaier
Examiner (ID: 9396, Phone: (571)272-1089 , Office: P/1762 )
Most Active Art Unit | 1712 |
Art Unit(s) | 1712, 1762, 1754, 1796, 2203, 1208, 1766, 2899, 1721 |
Total Applications | 1675 |
Issued Applications | 936 |
Pending Applications | 107 |
Abandoned Applications | 631 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 17183782
[patent_doc_number] => 20210330667
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-28
[patent_title] => TOPICAL COMPOSITION OF NALBUPHINE AND METHOD FOR TREATING PRURITUS CONDITION, PAIN, OR INFLAMMATORY CONDITION BY USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/368995
[patent_app_country] => US
[patent_app_date] => 2021-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4514
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17368995
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/368995 | TOPICAL COMPOSITION OF NALBUPHINE AND METHOD FOR TREATING PRURITUS CONDITION, PAIN, OR INFLAMMATORY CONDITION BY USING THE SAME | Jul 6, 2021 | Abandoned |
Array
(
[id] => 19012988
[patent_doc_number] => 11919903
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-03-05
[patent_title] => Polymorphs
[patent_app_type] => utility
[patent_app_number] => 17/363441
[patent_app_country] => US
[patent_app_date] => 2021-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 2568
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17363441
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/363441 | Polymorphs | Jun 29, 2021 | Issued |
Array
(
[id] => 18643336
[patent_doc_number] => 11767396
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-09-26
[patent_title] => Fluorine compounds
[patent_app_type] => utility
[patent_app_number] => 17/357193
[patent_app_country] => US
[patent_app_date] => 2021-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2759
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17357193
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/357193 | Fluorine compounds | Jun 23, 2021 | Issued |
Array
(
[id] => 18126249
[patent_doc_number] => 20230011869
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-12
[patent_title] => NOVEL IMIDAZOPYRAZINE DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 17/349800
[patent_app_country] => US
[patent_app_date] => 2021-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 63044
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17349800
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/349800 | NOVEL IMIDAZOPYRAZINE DERIVATIVES | Jun 15, 2021 | Pending |
Array
(
[id] => 18148867
[patent_doc_number] => 20230022724
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-26
[patent_title] => NOVEL IMIDAZOPYRAZINE DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 17/349760
[patent_app_country] => US
[patent_app_date] => 2021-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 55928
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17349760
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/349760 | NOVEL IMIDAZOPYRAZINE DERIVATIVES | Jun 15, 2021 | Pending |
Array
(
[id] => 17272786
[patent_doc_number] => 20210378984
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-09
[patent_title] => REDUCTION OF ADIPOSE TISSUE
[patent_app_type] => utility
[patent_app_number] => 17/348527
[patent_app_country] => US
[patent_app_date] => 2021-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 51031
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17348527
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/348527 | REDUCTION OF ADIPOSE TISSUE | Jun 14, 2021 | Pending |
Array
(
[id] => 17548021
[patent_doc_number] => 20220119362
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-21
[patent_title] => DEUTERATED 1-PIPERAZINO-3-PHENYL INDANES FOR TREATMENT OF SCHIZOPHRENIA
[patent_app_type] => utility
[patent_app_number] => 17/340201
[patent_app_country] => US
[patent_app_date] => 2021-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18093
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17340201
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/340201 | DEUTERATED 1-PIPERAZINO-3-PHENYL INDANES FOR TREATMENT OF SCHIZOPHRENIA | Jun 6, 2021 | Pending |
Array
(
[id] => 17256688
[patent_doc_number] => 20210369673
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-02
[patent_title] => Chlorthalidone Compositions And Methods
[patent_app_type] => utility
[patent_app_number] => 17/331011
[patent_app_country] => US
[patent_app_date] => 2021-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11726
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 125
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17331011
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/331011 | Chlorthalidone compositions and methods | May 25, 2021 | Issued |
Array
(
[id] => 17081977
[patent_doc_number] => 20210276983
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-09
[patent_title] => CRYSTALLINE FORMS OF 6-((6,7-DIMETHOXYQUINAZOLIN-4-YL)OXY)-N,2-DIMETHYLBENZOFURAN-3-CARBOXAMIDE
[patent_app_type] => utility
[patent_app_number] => 17/303114
[patent_app_country] => US
[patent_app_date] => 2021-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17600
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17303114
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/303114 | Crystalline forms of 6-((6,7-dimethoxyquinazolin-4-yl)oxy)-n,2-dimethylbenzofuran-3-carboxamide | May 19, 2021 | Issued |
Array
(
[id] => 18887689
[patent_doc_number] => 11866450
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-09
[patent_title] => Modulators of Cystic Fibrosis Transmembrane Conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulators
[patent_app_type] => utility
[patent_app_number] => 17/323267
[patent_app_country] => US
[patent_app_date] => 2021-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 43
[patent_figures_cnt] => 2
[patent_no_of_words] => 221773
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17323267
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/323267 | Modulators of Cystic Fibrosis Transmembrane Conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulators | May 17, 2021 | Issued |
Array
(
[id] => 17080540
[patent_doc_number] => 20210275546
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-09
[patent_title] => HIGH DRUG LOAD SOLID ORAL DOSAGE FORMS OF DEXAMETHASONE
[patent_app_type] => utility
[patent_app_number] => 17/319487
[patent_app_country] => US
[patent_app_date] => 2021-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9748
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17319487
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/319487 | HIGH DRUG LOAD SOLID ORAL DOSAGE FORMS OF DEXAMETHASONE | May 12, 2021 | Abandoned |
Array
(
[id] => 17066187
[patent_doc_number] => 20210268402
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-02
[patent_title] => PURIFICATION AND SEPARATION TECHNIQUES FOR CANNABINOIDS
[patent_app_type] => utility
[patent_app_number] => 17/308574
[patent_app_country] => US
[patent_app_date] => 2021-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3514
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17308574
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/308574 | PURIFICATION AND SEPARATION TECHNIQUES FOR CANNABINOIDS | May 4, 2021 | Abandoned |
Array
(
[id] => 18701280
[patent_doc_number] => 11787779
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-17
[patent_title] => Sulfone pyridine alkyl amide-substituted heteroaryl compounds
[patent_app_type] => utility
[patent_app_number] => 17/242428
[patent_app_country] => US
[patent_app_date] => 2021-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28917
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17242428
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/242428 | Sulfone pyridine alkyl amide-substituted heteroaryl compounds | Apr 27, 2021 | Issued |
Array
(
[id] => 18590208
[patent_doc_number] => 11739088
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-29
[patent_title] => Synthesis of heterocyclic compounds
[patent_app_type] => utility
[patent_app_number] => 17/243358
[patent_app_country] => US
[patent_app_date] => 2021-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10745
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17243358
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/243358 | Synthesis of heterocyclic compounds | Apr 27, 2021 | Issued |
Array
(
[id] => 16977550
[patent_doc_number] => 20210221787
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-22
[patent_title] => NIRAPARIB SOLID STATE FORM
[patent_app_type] => utility
[patent_app_number] => 17/301465
[patent_app_country] => US
[patent_app_date] => 2021-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3520
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17301465
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/301465 | Niraparib solid state form | Apr 4, 2021 | Issued |
Array
(
[id] => 19135560
[patent_doc_number] => 11970490
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-30
[patent_title] => Stable heavy isotopes in amide functional groups and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/212032
[patent_app_country] => US
[patent_app_date] => 2021-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 9
[patent_no_of_words] => 24724
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17212032
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/212032 | Stable heavy isotopes in amide functional groups and uses thereof | Mar 24, 2021 | Issued |
Array
(
[id] => 18685113
[patent_doc_number] => 11780830
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-10
[patent_title] => Triazolone derivatives or salts thereof and pharmaceutical compositions comprising the same
[patent_app_type] => utility
[patent_app_number] => 17/208887
[patent_app_country] => US
[patent_app_date] => 2021-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48140
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 119
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17208887
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/208887 | Triazolone derivatives or salts thereof and pharmaceutical compositions comprising the same | Mar 21, 2021 | Issued |
Array
(
[id] => 18590206
[patent_doc_number] => 11739086
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-29
[patent_title] => Substituted pyrrolopyridine JAK inhibitors and methods of making and using the same
[patent_app_type] => utility
[patent_app_number] => 17/203482
[patent_app_country] => US
[patent_app_date] => 2021-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44001
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17203482
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/203482 | Substituted pyrrolopyridine JAK inhibitors and methods of making and using the same | Mar 15, 2021 | Issued |
Array
(
[id] => 18134716
[patent_doc_number] => 11560369
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-01-24
[patent_title] => Crystalline forms and processes for the preparation of cannabinoid receptor modulators
[patent_app_type] => utility
[patent_app_number] => 17/202946
[patent_app_country] => US
[patent_app_date] => 2021-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 26180
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17202946
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/202946 | Crystalline forms and processes for the preparation of cannabinoid receptor modulators | Mar 15, 2021 | Issued |
Array
(
[id] => 16932300
[patent_doc_number] => 20210198189
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-01
[patent_title] => NOVEL INHIBITORS OF MEPRIN ALPHA AND BETA
[patent_app_type] => utility
[patent_app_number] => 17/195391
[patent_app_country] => US
[patent_app_date] => 2021-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8215
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17195391
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/195391 | NOVEL INHIBITORS OF MEPRIN ALPHA AND BETA | Mar 7, 2021 | Pending |